Data as of Jul 21
| -0.15 / -1.69%|
The 2 analysts offering 12-month price forecasts for Symmetry Medical Inc have a median target of 12.50, with a high estimate of 13.00 and a low estimate of 12.00. The median estimate represents a +43.35% increase from the last price of 8.72.
The current consensus among 4 polled investment analysts is to Buy stock in Symmetry Medical Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.